Home Health Goa to start administering Remdesivir to Covid-19 patients

Goa to start administering Remdesivir to Covid-19 patients

Goa’s Health Ministry on Friday received 1,008 vials of Remdesivir from pharma major Cipla. Remdesivir is an anti-viral drug that is administered to Covid-19 patients and results in faster recovery, state Health Minister Vishwajit Rane said.

“This anti-viral drug will be beneficial in suppressing the viral replication of SARS-CoV-2, the coronavirus that causes COVID-19. Uncontrollable viral replication is often responsible for tissue damage and deaths in patients infected with the virus,” Rane said in a statement.

The minister also said that the anti-viral drug will be administered to moderately and severely-ill patients suffering from COVID-19 and would help to suppress the viral replication of SARS-CoV-2.

“The drug will help in faster recovery of COVID-19 patients. Introduction of Remdesivir in the COVID-19 treatment protocol will also help us reduce COVID-19 deaths associated with co-morbidity,” Rane said.

Goa is currently witnessing a sustained spike in the number of Covid-19 cases. The state has recorded 7,614 coronavirus cases in all, out of which 2,095 are active. 66 people have died after contracting the deadly infection.

Most Popular

Judge temporarily blocks Trump admin’s TikTok ban

A US federal judge has temporarily blocked President Donald Trump's administration's ban on the Chinese short video-making app, TikTok just hours before it was...

Best save ever seen in my life: Sachin on Pooran’s fielding effort

Master Blaster Sachin Tendulkar was full of praise for Nicholas Pooran after the West Indian came out with a stunning fielding effort during Kings...

Anirban Lahiri enjoys T6 finish at Corales Puntacana Championship

India's Anirban Lahiri enjoyed his first top-10 on the PGA Tour in nearly two years following a tied sixth finish at the Corales Puntacana...

Samsung may log $54.5bn in sales, to sell 80mn Galaxy phones in Q3

Samsung is expected to report strong third-quarter earnings, analysts said on Monday, as its mainstay semiconductor business remained solid despite a decline in memory...